Printer Friendly
The Free Library
19,595,259 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Columbia Laboratories to Hold Second Quarter 2005 Financial Results Conference Call on August 2, 2005.


LIVINGSTON, N.J. -- Columbia Laboratories, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: CBRX) will hold a conference call on August 2, 2005 to review financial results of the second quarter ended June 30, 2005. The call will be hosted by Fred Wilkinson, President and Chief Executive Officer and David Weinberg, Chief Financial Officer.
Access information
Date:                         Tuesday, August 2, 2005
Time:                         11:00 AM ET
U.S./Canada dial-in number:   (800) 299-0433
International dial-in number: (617) 801-9712
Participant passcode:         20683035
Live webcast:                 www.columbialabs.com, under the events
                              tab


Replay Access Information

A recording of the conference call will be available two hours after completion until August 9, 2005 at 11:59 PM ET at (888) 286-8010 (U.S.) and (617) 801-6888 (International). The replay password is 56268229. The webcast will be archived for on-demand listening for one year on Columbia Laboratories website, www.columbialabs.com.

About Columbia Laboratories, Inc.

Columbia Laboratories, Inc. is a U.S.-based international pharmaceutical company dedicated to the development and commercialization of women's health care and endocrinology products, including those intended to treat infertility, dysmenorrhea dysmenorrhea

Pain or cramps before or during menstruation. In primary dysmenorrhea, caused by endocrine imbalances, severity varies widely. Irritability, fatigue, backache, or nausea may also occur.
, endometriosis and hormonal deficiencies and to prevent preterm preterm /pre·term/ (-term´) before completion of the full term; said of pregnancy or of an infant.

pre·term
adj.
 birth. Columbia markets Striant(R) (testosterone buccal buc·cal
adj.
1. Of, relating to, adjacent to, or in the direction of the cheek.

2. Of or relating to the mouth cavity.


buccal
 system) for the treatment of hypogonadism Hypogonadism Definition

Hypogonadism is the condition more prevalent in males in which the production of sex hormones and germ cells are inadequate.
 in men, Prochieve(R) 8% (progesterone gel) for progesterone supplementation as part of an Assisted Reproductive Technology Assisted reproductive technology (ART) is a general term referring to methods used to achieve pregnancy by artificial or partially artificial means. It is reproductive technology used in infertility treatment, which is the only application routinely used today of  treatment for infertile women with progesterone deficiency, and Prochieve(R) 4% (progesterone gel) for the treatment of secondary amenorrhea. Columbia's products and product candidates utilize the company's bioadhesive drug delivery technology. The Company is investigating the potential utility of Prochieve 8% in the prevention of preterm birth and developing a vaginally-administered lidocaine lidocaine /li·do·caine/ (li´do-kan) an anesthetic with sedative, analgesic, and cardiac depressant properties, applied topically in the form of the base or hydrochloride salt as a local anesthetic; also used in the latter form as a  product to treat dysmenorrhea and pelvic pain. The Company has developed a buccal delivery system for peptides. For more information, please visit www.columbialabs.com.

Striant(R) and Prochieve(R) are registered trademarks of Columbia Laboratories, Inc.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 19, 2005
Words:303
Previous Article:Arnaud Peres Joins Davis Polk & Wardwell; First Partner to Practice Non-U.S. Law.
Next Article:Zacks Sell List Highlights AirTran Holdings, Open Text, DreamWorks Animation SKG, Majesco Entertainment.
Topics:



Related Articles
CBL & Associates Properties Sets Second Quarter Earnings Release and Conference Call Dates.
Diagnostic Products Corporation Schedules Conference Call to Discuss Second Quarter 2005 Results.
Wescast Industries Inc. Hosts Conference Call and Webcast to Discuss 2nd Quarter Earnings.
Susquehanna Bancshares, Inc. Declares Dividend and Announces Second Quarter Earnings Webcast Conference Call.
FBL Financial Group Schedules Second Quarter 2005 Earnings Date, Conference Call and Webcast.
GenVec to Host Second Quarter Earnings Call and Webcast on August 3.
Columbia Laboratories Reports Second Quarter 2005 Financial Results; Net Revenues up 36%, Operating Expenses Down 38%, from Prior Year Period.
Columbia Laboratories Reports Third Quarter 2005 Results; Net Revenues up 28%, Operating Expenses Down 41% from Prior Year Period.
Columbia Laboratories Reports Second Quarter 2006 Financial Results; Management to Host Conference Call at 11:00 am Today.
Columbia Laboratories Reports Third Quarter 2006 Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles